Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 7,7x - 8,5x | 8,1x |
| Selected Fwd EBITDA Multiple | 7,2x - 8,0x | 7,6x |
| Fair Value | €0,41 - €0,46 | €0,44 |
| Upside | -3,0% - 9,5% | 3,2% |
| Benchmarks | Ticker | Full Ticker |
| Teva Pharmaceutical Industries Limited | TEVJ.F | OTCPK:TEVJ.F |
| Sanofi | SANOFI80 | SET:SANOFI80 |
| Sumitomo Pharma Co., Ltd. | 4506 | TSE:4506 |
| Eisai Co., Ltd. | 4523 | TSE:4523 |
| Beijing Biostar Pharmaceuticals Co., Ltd. | 2563 | SEHK:2563 |
| Luye Pharma Group Ltd. | LUP | DB:LUP |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| TEVJ.F | SANOFI80 | 4506 | 4523 | 2563 | LUP | ||
| OTCPK:TEVJ.F | SET:SANOFI80 | TSE:4506 | TSE:4523 | SEHK:2563 | DB:LUP | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 0.0% | 2.9% | -17.4% | -11.1% | NM- | -1.3% | |
| 3Y CAGR | 0.2% | 1.2% | -26.8% | 2.5% | NM- | 27.8% | |
| Latest Twelve Months | -0.2% | -0.4% | 112.2% | 4.2% | 23.3% | 21.8% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 27.0% | 28.3% | -14.3% | 12.8% | -374.7% | 24.8% | |
| Prior Fiscal Year | 27.3% | 26.9% | -100.9% | 11.3% | -311.1% | 25.3% | |
| Latest Fiscal Year | 26.8% | 26.3% | 9.7% | 11.0% | -221.1% | 31.2% | |
| Latest Twelve Months | 26.8% | 26.9% | 9.7% | 11.0% | -221.1% | 31.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 2.05x | 2.54x | 1.70x | 1.31x | NA | 2.78x | |
| EV / LTM EBITDA | 7.6x | 9.4x | 17.6x | 11.9x | NA | 8.9x | |
| EV / LTM EBIT | 9.9x | 12.2x | 52.1x | 22.0x | NA | 14.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 7.6x | 10.7x | 17.6x | ||||
| Historical EV / LTM EBITDA | 8.0x | 9.9x | 12.8x | ||||
| Selected EV / LTM EBITDA | 7.7x | 8.1x | 8.5x | ||||
| (x) LTM EBITDA | 1,892 | 1,892 | 1,892 | ||||
| (=) Implied Enterprise Value | 14,611 | 15,380 | 16,149 | ||||
| (-) Non-shareholder Claims * | (2,925) | (2,925) | (2,925) | ||||
| (=) Equity Value | 11,686 | 12,455 | 13,224 | ||||
| (/) Shares Outstanding | 3,761.7 | 3,761.7 | 3,761.7 | ||||
| Implied Value Range | 3.11 | 3.31 | 3.52 | ||||
| FX Rate: CNY/EUR | 8.4 | 8.4 | 8.4 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.37 | 0.39 | 0.42 | 0.42 | |||
| Upside / (Downside) | -13.0% | -7.2% | -1.5% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | TEVJ.F | SANOFI80 | 4506 | 4523 | 2563 | LUP | |
| Enterprise Value | 34,379 | 115,171 | 674,085 | 1,034,019 | 1,585 | 16,353 | |
| (+) Cash & Short Term Investments | 1,697 | 7,556 | 23,116 | 265,561 | 0 | 6,503 | |
| (+) Investments & Other | 0 | 0 | 72,339 | 90,785 | 0 | 2,492 | |
| (-) Debt | (16,939) | (17,913) | (314,246) | (187,522) | 0 | (10,321) | |
| (-) Other Liabilities | (7) | 0 | 0 | (24,551) | 0 | (1,599) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 19,130 | 104,814 | 455,294 | 1,178,292 | 1,585 | 13,429 | |
| (/) Shares Outstanding | 1,366.4 | 1,230,228.0 | 397.3 | 281.9 | 216.7 | 3,761.7 | |
| Implied Stock Price | 14.00 | 0.09 | 1,146.00 | 4,180.00 | 7.31 | 3.57 | |
| FX Conversion Rate to Trading Currency | 1.00 | 0.03 | 1.00 | 1.00 | 0.91 | 8.42 | |
| Implied Stock Price (Trading Cur) | 14.00 | 3.24 | 1,146.00 | 4,180.00 | 8.01 | 0.42 | |
| Trading Currency | USD | THB | JPY | JPY | HKD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 0.03 | 1.00 | 1.00 | 0.91 | 8.42 | |